Dividend compounder review
BSX
Boston Scientific Corp · NYSE · US
Healthcare · Medical Devices
Score51.00/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Quality breakdown
Dividend Reliability
0.0 / 25
Payment history, cuts, growth, and regularity.
Dividend Sustainability
17.0 / 20
Payout, free cash flow, dividend cover, and debt.
Business Quality
24.0 / 25
Scale, cash generation, growth, margins, and returns.
Valuation Discipline
6.0 / 15
Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend
4.0 / 15
Trend line, long return history, and drawdown control.
Dividend and business context
Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$2.9B
Free Cash Flow$3.4B
FCF Covers DividendUnknown
Debt / Equity0.42
P/E19.6
Revenue Growth 5Y15.2%
Net Margin17.3%
ROE14.7%
Price vs Trend-37.3%
3Y Return-13.1%
5Y Return6.4%
CurrencyUSD
Review flags
No usable dividend history found.
Activity record
No usable dividend history found.